Skip to main content
Signal8

Kapoor Vishal

SEC insider (Form 3/4/5 filer). CIK 0001798946. Director at Jasper Therapeutics, Inc. (JSPR). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 3, 2025. Located in REDWOOD CITY, CA.

Companies Kapoor Vishal has filed insider reports for

  • Jasper Therapeutics, Inc. (JSPR): Director
Kapoor Vishal profile photo

Kapoor Vishal

CIK: 0001798946

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 3, 2025
    Award

    Stock Option (right to buy)

    Direct
    7.5K shares-

1-1 of 1